Abstract
Background Outbreak strains are good candidates to look for intrinsic transmissibility as they are responsible for a large number of cases with sustained transmission. However, assessment of the success of long-lived outbreak strains has been flawed by the use of low-resolution typing methods and restricted geographical investigations. We now have the potential to address the nature of outbreak strains by combining large genomic datasets and phylodynamic approaches.
Methods We retrospectively sequenced the whole genome of representative samples assigned to an outbreak circulating in the Canary Islands (GC) since 1993; accounting for ∼20% of local TB cases. We selected a panel of specific SNP markers to in-silico search for additional outbreak related sequences within publicly-available TB genomic data. Using this information we inferred the origin, spread and epidemiological parameters of the GC-outbreak.
Findings Our approach allowed us to accurately trace both the historical and recent dispersion of the strain. We evidenced its high success within the Canarian archipelago but found a limited expansion abroad. Estimation of epidemiological parameters from genomic data contradicts a distinct biology of the GC-strain.
Interpretation With the increasing availability of genomic data allowing for an accurate inference of strain spread and key epidemiological parameters, we can now revisit the link between Mycobacterium tuberculosis genotypes and transmission, as routinely done for SARS-CoV-2 variants of concern. We show that the success of the GC-strain is better explained by social determinants rather than intrinsically higher bacterial transmissibility. Our approach can be used to trace and characterize strains of interest worldwide.
Funding European Research Council (101001038-TB-RECONNECT), the Ministerio de Economía, Industria y Competitividad (PID2019-104477RB-I00), Instituto de Salud Carlos III (FIS18/0336), European Commission –NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global) to IC. Gobierno de Aragón/Fondo Social Europeo “Construyendo Europa desde Aragón” to SS
Evidence before this study Identification of intrinsically highly transmissible strains of Mycobacterium tuberculosis remains elusive. Among candidates are those strains that have been thriving in a community for decades representing a significant contribution to the long-term local TB burden. These long-lived outbreak strains have been identified in different parts of the world and the speculation is that their success is linked to higher transmissibility. Several studies have attempted to analyze the epidemiological characteristics of these strains as well as their genomic composition to look for potential transmission determinants. However those studies are usually circunscribe to their original geographic boundaries. By contrast, this transmissibility should be replicated in different parts of the world, a lesson learnt from SARS-CoV-2 variants of concern. Previous attempts failed to examine the success of these outbreak strains at a global scale. Thus, it is unknown whether the long-lived outbreak strains had a similar or different trajectory in other countries, casting doubts about their transmissibility potential.
Added value of this study Here we analyzed a strain causing a long-lived outbreak in the Canary Islands since 1993 using whole genome sequencing. As in previous studies with other similar outbreak strains, we analyzed the diversity and phylodynamics of the outbreak in the area where it was originally described. However, thanks to the possibility of interrogating the entire European Nucleotide Archive, we had the unique chance to look at the spread of the strains beyond its original geographic boundaries. This approach allowed us to comprehensively trace the real spatio-temporal spread of the outbreak from the emergence of its ancestor about 700 years ago to its recent transmission outside the Canary Islands. As a result, there is limited evidence for similar success of the strains outside Canary Islands. Furthermore, we complemented the analysis with epidemiological data of the early cases and with phylodynamic analysis to estimate key epidemiological parameters linked to the strain spread. All evidence strongly suggests that factors related to the host, instead of the bacteria, are behind the persistence and expansion of the outbreak strain.
Implications of all the available evidence Infectious disease outbreaks are a major problem for public health. Tracing outbreak expansion and knowing the main factors behind their emergence and persistence are key to an effective disease control. Our study allows researchers and public health authorities to use WGS-based methods to trace outbreaks, and include available epidemiological information to evaluate the factors underpinning outbreak persistence. Taking advantage of all the information freely available in public repositories, researchers can accurately establish the expansion of the outbreak behind its original boundaries; and they can determine the potential risk of the strain to inform health authorities which, in turn, can define target strategies to mitigate its expansion and persistence. Finally, we show the need to evaluate strain transmissibility in different geographic contexts to unequivocally associate its spread to local or pathogen factors, a major lesson taken from SARS-CoV-2 genomic surveillance.
Competing Interest Statement
IC received consultancy fees from Foundation for Innovative New Diagnostics. The author has no other competing interests to declare. The remaining authors declare no competing interests.
Funding Statement
This study was founded by Instituto de Salud Carlos III (FIS18/0336), Gobierno de Aragon/Fondo Social Europeo Construyendo Europa desde Aragon to SS. European Research Council (101001038-TB-RECONNECT), the Ministerio de Economia, Industria y Competividad (PID2019-104477RB-I00) to IC.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Hospital Universitario de Gran Canaria Dr. Negrin under Ethics Committee Application CEIm H.U.G.C. Dr. Negrin 2019-502-1 gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Availability of different type of data is described in detail in the mansucscript